Analysts Conflicted on These Healthcare Names: Roche Holding AG (OtherRHHVF) and Qiagen (QGEN)
Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on Roche Holding AG (RHHVF) and Qiagen (QGEN).
Roche Holding AG (RHHVF)
In a report released today, Richard Vosser from J.P. Morgan maintained a Hold rating on Roche Holding AG, with a price target of CHF310.00. The company’s shares closed last Tuesday at $349.00.
According to TipRanks.com, Vosser is a 4-star analyst with an average return of 10.8% and a 69.3% success rate. Vosser covers the Healthcare sector, focusing on stocks such as Molecular Partners AG, Roche Holding, and Sanofi.
Currently, the analyst consensus on Roche Holding AG is a Moderate Buy with an average price target of $388.85, a 12.2% upside from current levels. In a report issued on February 5, Deutsche Bank also maintained a Hold rating on the stock with a CHF325.00 price target.
See today’s analyst top recommended stocks >>
Berenberg Bank analyst Scott Bardo maintained a Buy rating on Qiagen today and set a price target of EUR52.00. The company’s shares closed last Tuesday at $54.06.
Bardo has an average return of 12.8% when recommending Qiagen.
According to TipRanks.com, Bardo is ranked #783 out of 7296 analysts.
The word on The Street in general, suggests a Hold analyst consensus rating for Qiagen with a $56.20 average price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.